| Title |
Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
|
|---|---|
| Published in |
European Journal of Nuclear Medicine and Molecular Imaging, October 2013
|
| DOI | 10.1007/s00259-013-2563-z |
| Pubmed ID | |
| Authors |
Cristina Müller, Josefine Reber, Stephanie Haller, Holger Dorrer, Peter Bernhardt, Konstantin Zhernosekov, Andreas Türler, Roger Schibli |
| Abstract |
The radiolanthanide (161)Tb (T 1/2 = 6.90 days, Eβ(-) av = 154 keV) was recently proposed as a potential alternative to (177)Lu (T 1/2 = 6.71 days, Eβ(-) av = 134 keV) due to similar physical decay characteristics but additional conversion and Auger electrons that may enhance the therapeutic efficacy. The goal of this study was to compare (161)Tb and (177)Lu in vitro and in vivo using a tumour-targeted DOTA-folate conjugate (cm09). |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 100 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 25 | 25% |
| Researcher | 13 | 13% |
| Student > Master | 12 | 12% |
| Other | 9 | 9% |
| Student > Bachelor | 6 | 6% |
| Other | 9 | 9% |
| Unknown | 26 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 22 | 22% |
| Physics and Astronomy | 13 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 10% |
| Medicine and Dentistry | 9 | 9% |
| Chemical Engineering | 4 | 4% |
| Other | 13 | 13% |
| Unknown | 29 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2023.
All research outputs
#7,320,351
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#883
of 3,083 outputs
Outputs of similar age
#64,654
of 211,390 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#8
of 40 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,390 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.